Difference between revisions of "Fibrocystic breast changes"
Jump to navigation
Jump to search
(→Differential diagnosis: Displayed) |
m (</noinclude>) |
||
Line 1: | Line 1: | ||
− | {{Top | + | <noinclude>{{Top |
|author1=[[User:Mikael Häggström|Mikael Häggström]] | |author1=[[User:Mikael Häggström|Mikael Häggström]] | ||
|author2= | |author2= | ||
Line 5: | Line 5: | ||
==Presentations== | ==Presentations== | ||
*[[Breast biopsy or excision]] | *[[Breast biopsy or excision]] | ||
− | + | </noinclude> | |
==Microscopic examination== | ==Microscopic examination== | ||
Types: | Types: |
Revision as of 00:00, 19 June 2022
Author:
Mikael Häggström [note 1]
Contents
Presentations
Microscopic examination
Types:
Sclerosing adenosis, with an increase in glandular elements in addition to stromal proliferation that distorts and compresses glands.[1]
Differential diagnosis
Sclerosing adenosis may look similar to invasive ductal carcinoma (IDC), but IDC will:[1]
- Not be lobular at low power
- Have marked cellular atypia
- Have no myoepithelial cells surrounding ducts.
When unsure, perform immunohistochemistry for myoepithelial markers (preferably p63 and calponin in breast lesions):
Notes
- ↑ For a full list of contributors, see article history. Creators of images are attributed at the image description pages, seen by clicking on the images. See Patholines:Authorship for details.
Main page
References
- ↑ 1.0 1.1 Jaya Ruth Asirvatham, M.B.B.S., Julie M. Jorns, M.D.. Breast - Fibrocystic changes - Sclerosing adenosis. Pathology Outlines. Topic Completed: 1 January 2015. Minor changes: 31 December 2020
Image sources